Peter Joseph Alff

Title: Peter Joseph Alff: Innovator in Viral Protein Research

Introduction

Peter Joseph Alff is a notable inventor based in New York, NY, with a focus on advancements in viral protein research. He holds a total of four patents that contribute significantly to the field of immunology and vaccine development. His work has implications for the treatment and prevention of viral infections, particularly respiratory syncytial virus (RSV) and influenza.

Latest Patents

One of his latest patents is titled "Conformationally stabilized RSV pre-fusion F proteins." This invention provides respiratory syncytial virus F proteins, polypeptides, and protein complexes that include cross-links to stabilize the protein in its pre-fusion conformation. The patent also discusses compositions that comprise these proteins, including vaccine formulations and methods for their use. Another significant patent is "Influenza hemagglutinin proteins and methods of use thereof." This invention offers influenza hemagglutinin polypeptides and proteins that maintain their native trimeric conformation, even when the head domain is disrupted. The patent outlines methods of using these proteins as vaccine immunogens.

Career Highlights

Peter has worked with prominent organizations such as Calder Biosciences Inc. and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His contributions in these roles have been pivotal in advancing research in viral proteins and their applications in vaccine development.

Collaborations

Throughout his career, Peter has collaborated with esteemed colleagues, including Claudio Bertuccioli and Christopher P Marshall. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Peter Joseph Alff is a distinguished inventor whose work in viral protein research has led to significant advancements in vaccine development. His patents reflect a commitment to improving public health through innovative solutions.